Importantly, our results indicated that overexpression of MORC2 associated with poor differentiation status of gastric cancer, tumor size, depth of invasion, distant metastasis, pathological stage and 5-year survival rate in clinical gastric cancer, suggesting that MORC2 may be involved in progression and prognosis of gastric cancer. The gene discussed is MORC2; the disease is neoplasm.